Wells Fargo’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$263K Sell
29,853
-881
-3% -$7.76K ﹤0.01% 4223
2025
Q1
$230K Buy
30,734
+1,033
+3% +$7.74K ﹤0.01% 4171
2024
Q4
$248K Buy
29,701
+11,744
+65% +$97.9K ﹤0.01% 4181
2024
Q3
$125K Sell
17,957
-9,424
-34% -$65.4K ﹤0.01% 4493
2024
Q2
$134K Buy
27,381
+3,473
+15% +$17K ﹤0.01% 4413
2024
Q1
$139K Buy
23,908
+149
+0.6% +$864 ﹤0.01% 4328
2023
Q4
$156K Buy
23,759
+2,788
+13% +$18.3K ﹤0.01% 4234
2023
Q3
$101K Buy
20,971
+2,921
+16% +$14.1K ﹤0.01% 4441
2023
Q2
$92.1K Buy
18,050
+12,973
+256% +$66.2K ﹤0.01% 4828
2023
Q1
$27.9K Buy
5,077
+3
+0.1% +$17 ﹤0.01% 5180
2022
Q4
$23.3K Sell
5,074
-76
-1% -$349 ﹤0.01% 4878
2022
Q3
$32K Sell
5,150
-1,037
-17% -$6.44K ﹤0.01% 4852
2022
Q2
$27K Sell
6,187
-2,939
-32% -$12.8K ﹤0.01% 5022
2022
Q1
$47K Sell
9,126
-10,406
-53% -$53.6K ﹤0.01% 5361
2021
Q4
$171K Sell
19,532
-19,739
-50% -$173K ﹤0.01% 4978
2021
Q3
$366K Buy
39,271
+33,552
+587% +$313K ﹤0.01% 4574
2021
Q2
$73K Buy
5,719
+2,394
+72% +$30.6K ﹤0.01% 5100
2021
Q1
$30K Buy
+3,325
New +$30K ﹤0.01% 5680
2020
Q2
Sell
-13
Closed 6477
2020
Q1
$0 Sell
13
-425
-97% ﹤0.01% 6446
2019
Q4
$3K Hold
438
﹤0.01% 5732
2019
Q3
$5K Sell
438
-62
-12% -$708 ﹤0.01% 5649
2019
Q2
$14K Hold
500
﹤0.01% 5482
2019
Q1
$13K Hold
500
﹤0.01% 5492
2018
Q4
$14K Sell
500
-1,031
-67% -$28.9K ﹤0.01% 5498
2018
Q3
$118K Hold
1,531
﹤0.01% 5058
2018
Q2
$159K Buy
1,531
+312
+26% +$32.4K ﹤0.01% 4952
2018
Q1
$154K Buy
1,219
+135
+12% +$17.1K ﹤0.01% 4906
2017
Q4
$71K Buy
1,084
+428
+65% +$28K ﹤0.01% 5178
2017
Q3
$39K Hold
656
﹤0.01% 5253
2017
Q2
$42K Sell
656
-125
-16% -$8K ﹤0.01% 5164
2017
Q1
$61K Buy
781
+62
+9% +$4.84K ﹤0.01% 5108
2016
Q4
$34K Buy
719
+219
+44% +$10.4K ﹤0.01% 5205
2016
Q3
$36K Buy
+500
New +$36K ﹤0.01% 5152
2016
Q2
Sell
-309
Closed -$72K 5992
2016
Q1
$72K Buy
309
+48
+18% +$11.2K ﹤0.01% 4878
2015
Q4
$83K Buy
+261
New +$83K ﹤0.01% 4864